Drugs / Monovalent live attenuated pandemic influenza vaccine
Monovalent live attenuated pandemic influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00981513 Comparator | Sep 2009 → Nov 2010 | influenza | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent live attenuated pandemic influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00981513 ↗ |
| Modality | Vaccine | “Live attenuated influenza vaccine (seasonal and pandemic strains)” NCT00981513 ↗ |
| Route | Intranasal | “Live attenuated influenza vaccine (seasonal and pandemic strains) by nasal spray” NCT00981513 ↗ |